Find out what's happening in the area of Horizon Europe, Digital Europe and Horizon 2020
the HORIZON-EIT-2024-WomenInnovatorsPrize call is now open for applications on the EU funding and tender portal. Deadline is 25 September 2024.
The European Prize for Women Innovators celebrates the women entrepreneurs behind Europe’s game-changing innovations, so that they may inspire other women and girls realise their full potential as the EU’s future scientists, innovators, and tech leaders.
This prize supports a culture within research and innovation organisations and companies allowing women to become the innovators and entrepreneurs of tomorrow.
The prize is awarded every year to women from across the EU and countries associated to Horizon Europe, who have transformed their ideas into disruptive innovations to benefit people and the planet.
Expected Impact:
The prize will boost public awareness of the potential, importance and contribution of women to the EU innovation ecosystem and create strong role models, inspiring more women to become innovators themselves.
2024-11-05
|
2 weeks ago |
NCP Flanders team: Reshuffle of responsibilities of our NCP Advisors - Horizon Europe... |
2024-10-25
|
4 weeks ago |
EIT Manufacturing: Innovate Together 2024 Call is open |
2024-10-08
|
1 month ago |
EIT Higher Education Institutions Initiatve: Open Call for Proposals 2024 on Innovati... |
2024-10-07
|
1 month ago |
EIT Health Flagships 2025 - Call on Digital Transformation of Healthcare |
2024-08-21
|
3 months ago |
Networking Platform Launched for EIT Water |
2024-08-09
|
3 months ago |
EIT Community New European Bauhaus (NEB) 2025 Open Calls |
2024-07-17
|
4 months ago |
Greenlight for EIT Water |
2024-07-01
|
4 months ago |
European Commission approves launch of a new KIC on water, marine and maritime ecosys... |
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
Deployment: Best use of technologies
The European Commission (DG CONNECT) has launched the following procurement procedure: Better Internet for Kids (BIK) Platform – EU Coordination (EC-CNECT/LUX/2024/OP/0097) The EU-funded Better Internet for Kids portal (at https://better-internet-for-kids.europa.eu) and the associated coordination tasks are the main subject of th... read more
Digital, Industry & Space AI, data & cloud
The European Commission’s Artificial Intelligence (AI) Office has launched a targeted stakeholders consultation process on the future guidelines on the AI system definition and the implementation of AI practices that pose unacceptable risks under the AI Act. The guidelines will help national competent authorities as well as providers and dep... read more
Digital, Industry & Space AI, data & cloud
The European Commission has published the first draft of the General-Purpose Artificial Intelligence (AI) Code of Practice. The rules governing general-purpose AI models under the AI Act will come into application in August 2025. The Code of Practice aims to facilitate the proper implementation of these rules and will play a crucial role in guidin... read more
The Horizon2020 project BEAT-AF brings together 9 European renowned clinical centres in France, Belgium, Czechia, Germany and Austria. Together, the consortium strives to revolutionize Atrial Fibrillation (AF) treatment through catheter ablation and contribute to decrease the huge burden of AF in Europe. The BEAT-AF project kicked off in 2021 and will run until 2026. The department of electrophysiology of the AZ Sint-Jan Hospital in Bruges is partner in the project and has so far contributed to the pre-clinical development, the first in man studies and first registries of the revolutionary AF treatment put forward by the consortium. The first pilot studies show that the treatment is safe, effective and efficient.